ACLX · As filed with the SEC
Arcellx cash flow statement, by fiscal year
The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | Year ended Dec 31, 2021 Year ended Dec 31, 2021 |
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | (228,934,000) | (107,348,000) | (70,690,000) | (188,679,000) | (64,969,000) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | 6,678,000 | 5,188,000 | 2,040,000 | 1,321,000 | 1,041,000 |
| Loss on disposal of property and equipment | 82,000 | (260,000) | 174,000 | 3,000 | 3,000 |
| Noncash operating lease expense | — | 3,310,000 | 1,010,000 | 903,000 | — |
| Noncash operating lease expense | (38,000) | — | — | — | — |
| Right of use asset expensed | 0 | 794,000 | 18,871,000 | 63,278,000 | — |
| Amortization of premiums and discounts on marketable securities | (8,443,000) | (15,459,000) | (11,048,000) | (2,125,000) | 210,000 |
| Share-based compensation | 77,891,000 | 61,086,000 | 41,789,000 | 21,544,000 | 6,754,000 |
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current and non-current assets | (2,211,000) | 8,611,000 | (8,359,000) | (5,695,000) | (6,059,000) |
| Accounts payable and other current liabilities | 2,664,000 | (70,000) | (6,474,000) | 7,419,000 | 974,000 |
| Accrued liabilities | (21,437,000) | 42,009,000 | 5,593,000 | (395,000) | 7,764,000 |
| Operating lease liabilities | (1,931,000) | (3,767,000) | 13,461,000 | 3,123,000 | — |
| Deferred rent | — | — | — | — | 44,000 |
| Contract liability to related party | (25,986,000) | (86,154,000) | 221,206,000 | — | — |
| Other non-current liabilities | (8,593,000) | 8,593,000 | — | — | — |
| Net cash provided by (used in) operating activities | (210,258,000) | (83,467,000) | 207,573,000 | (99,303,000) | (54,238,000) |
| Cash flows from investing activities | |||||
| Purchases of property and equipment | (2,327,000) | (13,434,000) | (21,428,000) | (2,277,000) | (5,783,000) |
| Purchases of marketable securities | (406,976,000) | (597,311,000) | (442,429,000) | (273,737,000) | (74,193,000) |
| Proceeds from maturities of marketable securities | 495,600,000 | 427,700,000 | 309,345,000 | 158,340,000 | — |
| Net cash provided by (used in) investing activities | 86,297,000 | (183,045,000) | (154,512,000) | (117,674,000) | (79,976,000) |
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock in private placement, net of transactions costs | 0 | — | 299,706,000 | 9,958,000 | — |
| Proceeds from issuance of common stock in offerings, net of issuance costs | 131,562,000 | — | — | 129,156,000 | — |
| Proceeds from exercise of stock options | 4,321,000 | — | — | — | — |
| Proceeds from issuance of common stock (follow-on offering), net of transactions costs | — | — | — | 120,719,000 | — |
| Proceeds from issuance of Series C redeemable convertible preferred stock, net of transaction costs | — | — | — | — | 119,118,000 |
| Proceeds from exercise of stock options and early exercise of restricted stock | — | 14,595,000 | 7,758,000 | 2,467,000 | 432,000 |
| Payments for repurchase of restricted stock | — | — | — | — | (24,000) |
| Proceeds from issuance of common stock under the employee stock purchase plan | 1,303,000 | 1,164,000 | 1,091,000 | — | — |
| Payments under finance leases | (230,000) | (39,846,000) | (29,392,000) | (9,675,000) | — |
| Payments under capital leases | — | — | — | — | (387,000) |
| Payments of deferred offering costs | — | — | — | — | (688,000) |
| Tax withholding payments related to net share settlement of restricted stock units | (38,422,000) | — | — | — | — |
| Net cash provided by (used in) financing activities | 98,534,000 | (24,087,000) | 279,163,000 | 252,625,000 | 118,451,000 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | (25,427,000) | (290,599,000) | 332,224,000 | 35,648,000 | (15,763,000) |
| Cash and cash equivalents and restricted cash, beginning of the year | 108,305,000 | 398,904,000 | 66,680,000 | 31,032,000 | 46,795,000 |
| Cash and cash equivalents and restricted cash, end of the year | 82,878,000 | 108,305,000 | 398,904,000 | 66,680,000 | 31,032,000 |
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for income taxes | 1,319,000 | 1,635,000 | 212,000 | — | — |
| Supplemental disclosures of noncash investing and financing activities: | |||||
| Purchase of property and equipment included in accounts payable and accrued liabilities | 944,000 | 325,000 | 1,841,000 | 770,000 | 278,000 |
| Deferred offering costs included in accounts payable and accrued liabilities | — | — | — | — | 1,301,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.